Skip to main content
. 2023 Mar 17;12(4):185–193. doi: 10.1093/stcltm/szad009

Table 3.

Clinical evaluations.

Site Participant ID Time to death (days) Duration of corticosteroid use (days) Duration of neuromuscular blocker use (days) Duration of prone ventilation (days)
Duke 1 7 5 4
Duke 2 8
Duke 3 39 5 17 6
Duke 4 9
Duke 5 76 10 6 1
Duke 6 27 10 3
Duke 7 20 9 7 1
Duke 8 6 .
Baptist Health 9 3
Baptist Health 10 16 16
Median (range) 27 (7.0, 76) 9 (5, 10) 6 (3, 17) 4 (1, 16)